A detailed history of Css LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Css LLC holds 1,000 shares of VRTX stock, worth $408,180. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,000
Previous 700 42.86%
Holding current value
$408,180
Previous $328,000 41.77%
% of portfolio
0.05%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$460.0 - $505.78 $138,000 - $151,734
300 Added 42.86%
1,000 $465,000
Q1 2024

May 15, 2024

SELL
$407.69 - $446.08 $7.34 Million - $8.03 Million
-18,000 Reduced 96.26%
700 $292,000
Q4 2023

Feb 14, 2024

SELL
$343.0 - $410.68 $102,900 - $123,204
-300 Reduced 1.58%
18,700 $7.61 Million
Q3 2023

Nov 14, 2023

SELL
$338.18 - $362.46 $101,454 - $108,738
-300 Reduced 1.55%
19,000 $6.61 Million
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $408,746 - $457,483
1,300 Added 7.22%
19,300 $6.79 Million
Q1 2023

May 15, 2023

BUY
$283.23 - $323.1 $3.78 Million - $4.31 Million
13,336 Added 285.93%
18,000 $5.67 Million
Q4 2022

Feb 14, 2023

BUY
$285.76 - $321.48 $290,617 - $326,945
1,017 Added 27.89%
4,664 $1.35 Million
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $37,240 - $41,552
-136 Reduced 3.6%
3,647 $1.06 Million
Q2 2022

Aug 15, 2022

BUY
$234.96 - $292.55 $266,444 - $331,751
1,134 Added 42.81%
3,783 $1.07 Million
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $254,411 - $299,854
1,149 Added 76.6%
2,649 $691,000
Q4 2021

Feb 14, 2022

SELL
$177.01 - $223.45 $8.42 Million - $10.6 Million
-47,560 Reduced 96.94%
1,500 $329,000
Q3 2021

Nov 15, 2021

BUY
$181.39 - $202.99 $3.04 Million - $3.4 Million
16,744 Added 51.81%
49,060 $8.9 Million
Q2 2021

Aug 16, 2021

BUY
$187.49 - $221.1 $6.06 Million - $7.15 Million
32,316 New
32,316 $6.52 Million
Q2 2020

Aug 14, 2020

SELL
$225.48 - $295.8 $135,288 - $177,480
-600 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$199.77 - $247.81 $119,862 - $148,686
600 New
600 $143,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.